DXS INTERNATIONAL PLC

(AQSE: DXSP)

Publication of Investor Presentation

DXS International plc ("DXSP" or the "Company"), the AQSE quoted clinical decision support developer and supplier of clinical decision support systems, is pleased to confirm that an updated corporate presentation is now available for download from the Corporate Documents section of the Company’s website at https://www.dxs-systems.co.uk/corporate-documents.php

Contacts:

David Immelman      (Chief Executive)
DXS International plc		01252 719800
david@dxs-systems.com



https://www.dxs-systems.co.uk		 


Corporate Advisor

 		 
City & Merchant
David Papworth

 		020 7101 7676

 


Corporate Broker

 		 
Hybridan LLP
Claire Louise Noyce

 		020 3764 2341

 

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.


© OMX, source GlobeNewswire - EU Press Releases